PrAtlas - India's FSSAI Grants Novel Food Approval for NEM® brand eggshell membrane

Trending...

FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate

CARTHAGE, Mo. - PrAtlas -- Stratum Nutrition®, (a business of ESM Technologies), along with our Indian partner, Zenova Bionutrition Pvt., Ltd., are pleased to announce that FSSAI, the Food Safety Standards Authority of India, has granted pre-market approval of NEM® brand partially hydrolyzed chicken eggshell membrane powder, as it is known in India, on October 26, 2021. This approval was the culmination of a multi-year review by FSSAI of NEM's safety and quality substantiation, which is required for foods with a special medical purpose, novel foods, health supplements, and nutraceuticals in India.

"We are extremely gratified to receive approval from FSSAI, as this again validates the substantial scientific portfolio that supports NEM and its health claims. NEM, being ovo-vegetarian, makes a great combination with curcumin-based ingredients for joint health, and this approval should allow NEM to establish its place as an innovative, science-backed ingredient in India's consumer market." said Kevin J. Ruff, Ph.D., MBA, Sr. Director of Scientific & Regulatory Affairs for Stratum Nutrition.

More on PrAtlas

NEM is one of the few joint health ingredients, and the only eggshell membrane ingredient that is supported by a full portfolio of 16 research studies, including: 4 randomized placebo-controlled trials (2 of which are healthy person trials); 4 open label clinical trials (3 of which were conducted independently); veterinary trials, including one canine RCT; and a wide range of supporting in vitro and in vivo mechanism of action studies. In addition to subjective endpoints like joint pain and stiffness, recent clinical trials have included objective endpoints via the CTX-II cartilage degradation biomarker, giving the results additional credibility and substantiation.

Chris Haynes, Senior Director of Global Sales for Stratum Nutrition, said, "The long-term scientific efforts by Stratum to increase global acceptance of NEM as a joint health ingredient, which is fundamental for the health and well-being of the global population, continues. NEM's exponential success of country-by-country registration clearly demonstrates the scientific validation of its function and results. Governmental agencies require statistically significant science to grant approvals – NEM provides this and continues to gain regulatory acceptance everywhere it enters a market. India will be a solid and strategic market for Stratum moving forward."

More on PrAtlas

Stratum is the global leader in eggshell membrane science and technology for joint health support. For more information about NEM® and other ingredients, please visit www.stratumnutrition.com.

###

About Stratum Nutrition

Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, curQplus, LBiome™ Lactobacillus LB postbiotic, NatAxtinTM astaxanthin, as well as oral health probiotics, BLIS K12® and BLIS M18®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.